Closed-system manufacturing process for CAR-T cells
- 专利权人:
- Seattle Children's Hospital (DBA Seattle Children's Research Institute)
- 发明人:
- JENSEN, Michael C.,GUSTAFSON, Joshua
- 申请号:
- AU2019217363
- 公开号:
- AU2019217363A1
- 申请日:
- 2019.02.04
- 申请国别(地区):
- AU
- 年份:
- 2020
- 代理人:
- 摘要:
- Some embodiments provided herein relate to methods and compositions for making genetically modified T cells. In some such embodiments, CD4+ and CD8+ T cells are cultured in a single serum-free volume. In some embodiments, co-cultured CD4+ and CD8+ T cells can be transduced with a lentiviral vector, and a population of transduced T cells can be harvested within a shorter period of time than other conventional methods.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- CLOSED-SYSTEM MANUFACTURING PROCESS FOR CAR-T CELLS
- Membrane-based processes for reducing at least one impurity and making a concentrate comprising at least one natural component from a non-marine fatty acid oil mixture, and compositions resulting thereof
- MEMBRANE-BASED PROCESSES FOR REDUCING AT LEAST ONE IMPURITY AND MAKING A CONCENTRATE COMPRISING AT LEAST ONE NATURAL COMPONENT FROM A NON-MARINE FATTY ACID OIL MIXTURE, AND COMPOSITIONS RESULTING THEREOF
- MEMBRANE-BASED PROCESSES FOR REDUCING AT LEAST ONE IMPURITY AND MAKING A CONCENTRATE COMPRISING AT LEAST ONE NATURAL COMPONENT FROM A NON-MARINE FATTY ACID OIL MIXTURE, AND COMPOSITIONS RESULTING THEREOF
- Membrane-based processes for reducing at least one impurity and making a concentrate comprising at least one natural component from a non-marine fatty acid oil mixture, and compositions resulting thereof